 |
|  | Bibliographie
1. Hariz GM, Lindberg M, Bergenheim AT. Impact
of thalamic deep brain stimulation on disability and health related quality
of life in patients with essential tremor. J Neurol Neurosurg Psychiatry 2002;
72: 47-52
2. Martínez-Martín P, Valldeoriola F, Tolosa E et al. Bilateral
subthalamic nucleus stimulation and quality of life in advanced Parkinson's
disease. Mov Disord 2002; 17: 372-377
3. Rehncrona S, Johnels B, Widner H, et al. Long-term efficacy of thalamic deep
brain stimulation for tremor: double-blind assessments. Mov Disord 2003; 18:
163-170
4. Limousin P, Speelman JD, Gielen F et al. Multicentre European study of thalamic
stimulation in parkinsonian and essential tremor. J Neurol Neurosurg Psychiatry
1999; 66: 289-296
5. Deuschl G, Fogel W, Hahne M et al. Deep brain stimulation for Parkinson's
disease. J Neurol 2002; 249: III/36-III/39
6. Benabid AL, Pollak P, Louveau A et al. Combined thalamotomy and stimulation
stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson's disease.
Appl Neurophysiol 1987; 50: 344-346
7. Medtronic. Global clinical study report: Activa Parkinson's disease control
therapy (N1-3169). 1999
8. Limousin P, Krack P, Pollak P, Benabid AL et al. Electrical stimulation of
the subthalamic nucleus in advanced Parkinson's disease. New Engl J Med 1998;
339: 1105-1111
9. Tavella A, Bergamasco B, Bosticco E et al. Deep brain stimulation of the
subthalamic nucleus in Parkinson's disease: long-term follow up.Neurol Sci2002;
23: S111-S112
10. Molinuevo JL, Valldeoriola F, Tolosa E et al. Levodopa withdrawal after
bilateral subthalamic nucleus stimulation in advanced Parkinson's disease. Arch
Neurol 2000; 57: 983-988
11. Pollak P, Fraix V, Krack P, Benabid AL et al. Treatment Results:Parkinson's
disease. Mov Disord 2002; 17: S75-S83
12. Volkmann J, Allert N, Vogels J et al. Safety and efficacy of pallidal or
subthalamic nucleus stimulation in advanced PD. Neurology 2001; 56: 548-551
13. Moro E, Esselink RJA, Benabid AL et al. Response to levodopa in parkinsonian
patients with bilateral subthalamic nucleus stimulation. Brain 2002; 125: 2408-2417
14. Moro E, Scerrati M, Romito LMA et al. Chronic subthalamic nucleus stimulation
reduces medication requirements in Parkinson's disease. Neurology 1999; 53:
85-90
15. Lagrange E, Krack P, Moro E, Benabid AL et al. Bilateral subthalamic nucleus
stimulation improves health-related quality of life in PD. Neurology 2002; 59:
1976-1978
16. Kumar R, Lozano AM, Kim YJ et al. Double-blind evaluation of subthalamic
nucleus deep brain stimulation in advanced Parkinson's disease. Neurology 1998;
51: 850-856
17. Ardouin C, Pillon B, Peiffer E, Benabid AL et al. Bilateral subthalamic
or pallidal stimulation for Parkinson's disease affects neither memory nor executive
functions: a consecutive series of 62 patients. Ann Neurol 1999; 46: 217-223
18. Haberler C, Alesch F, Mazal PR et al. No tissue damage by chronic deep brain
stimulation in Parkinson's disease. Ann Neurol 2000; 48: 372-376
19. Vesper J, Chabardes S, Fraix V et al. Dual channel deep brain stimulation
system (Kinetra) for Parkinson's disease and essential tremor: a prospective
multicentre open label clinical study. J Neurol Neurosurg Psychiatry 2002; 73:
275-280
20. The Deep Brain Stimulation for Parkinson's Disease Study Group. Deep-brain
stimulation of the subthalamic nucleus or the pars interna of the globus pallidus
in Parkinson's disease. N Engl J Med 2001; 345: 956-963
21. Schuurman PR, Bosch DA, Bossuyt PMM et al. A comparison of continuous thalamic
stimulation and thalamotomy for suppression of severe tremor. New Engl J Med
2000; 342: 461-468
22. Troster AI, Pahwa R et al. Neuropsychological and quality of life outcome
after thalamic stimulation for essential tremor. Neurology 1999; 53: 1774-1780
23. Lang A, Widner H et al. Deep brain stimulation for Parkinson's disease:
Patient selection and evaluation. Mov Disord 2002; 17: S94-S101
24. Pahwa R, Lyons KL, Wilkinson SB et al. Bilateral thalamic stimulation for
the treatment of essential tremor. Neurology 1999; 53: 1447-1450
AVERTISSEMENT
: |
Les dispositifs médicaux présentés
dans ce document font lobjet d'indications et de contre-indications.
Il est impératif de se reporter au manuel avant toute utilisation
|
|